Presentation is loading. Please wait.

Presentation is loading. Please wait.

Kreton Mavromatis, MD, Vinod H

Published byΔιδώ Αλεξίου Modified over 5 years ago

Similar presentations

Presentation on theme: "Kreton Mavromatis, MD, Vinod H"— Presentation transcript:

1 Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation 
Kreton Mavromatis, MD, Vinod H. Thourani, MD, Amanda Stebbins, MS, Sreekanth Vemulapalli, MD, Chandan Devireddy, MD, Robert A. Guyton, MD, Roland Matsouaka, PhD, Nima Ghasemzadeh, MD, Peter C. Block, MD, Bradley G. Leshnower, MD, James P. Stewart, MD, John S. Rumsfeld, MD, PhD, Stamatios Lerakis, MD, Vasilis Babaliaros, MD  The Annals of Thoracic Surgery  Volume 104, Issue 6, Pages (December 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Clinical events after TAVR. (A) All cause mortality. (B) Heart failure rehospitalization. (C) Mortality or heart failure rehospitalization. (MR = mitral regurgitation.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Hazard ratio incurred by mitral regurgitation on clinical outcomes. Adjusted HRs derived from Cox regression analysis. Effect estimates (95% CI) compared with No MR. (A) 30-day mortality. (B) 30-day mortality or heart failure rehospitalization. (C) 1-year mortality. (D) 1-year mortality or heart failure rehospitalization. (Mod = moderate.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Mitral regurgitation in patients undergoing transcatheter aortic valve replacement. (Mod = moderate; MR = mitral regurgitation; TAVR = transcatheter aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Mortality after TAVR: patients with improved MR (>1 grade) versus no improvement. (A) Moderate and severe MR. (B) Moderate MR. (C) Severe MR. (MR = mitral regurgitation; TAVR = transcatheter aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Heart failure rehospitalization after TAVR: patients with improved MR (>1 grade) versus no improvement. (A) Moderate and severe MR. (B) Moderate MR. (C) Severe MR. (HF = heart failure; MR = mitral regurgitation; Rehosp = rehospitalization; TAVR = transcatheter aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Kreton Mavromatis, MD, Vinod H"

Similar presentations

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
A Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement  Hisato Takagi, MD, PhD, Masao Niwa, MD, Yusuke Mizuno,

A Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement  Hisato Takagi, MD, PhD, Masao Niwa, MD, Yusuke Mizuno,
Twenty-Five Year Experience With the St

Twenty-Five Year Experience With the St
Ten-year trends in heart valve replacement operations

Ten-year trends in heart valve replacement operations
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States 

The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States 
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis 

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis 
Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison  Dale M. Kobrin, BA, Fenton H. McCarthy, MD,

Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison  Dale M. Kobrin, BA, Fenton H. McCarthy, MD,
Transcatheter Aortic Valve Replacement Results in Improvement of Pulmonary Function in Patients With Severe Aortic Stenosis  Richard C. Gilmore, BA, Vinod.

Transcatheter Aortic Valve Replacement Results in Improvement of Pulmonary Function in Patients With Severe Aortic Stenosis  Richard C. Gilmore, BA, Vinod.
Surgeon Involvement in Transcatheter Aortic Valve Replacement in the United States: A 2016 Society of Thoracic Surgeons Survey  Joseph E. Bavaria, MD,

Surgeon Involvement in Transcatheter Aortic Valve Replacement in the United States: A 2016 Society of Thoracic Surgeons Survey  Joseph E. Bavaria, MD,
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,

Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,
Reply The Annals of Thoracic Surgery

Reply The Annals of Thoracic Surgery
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.
Clinical Outcomes of the David V Valve-Sparing Root Replacement Compared With Bioprosthetic Valve-Conduits for Aortic Root Aneurysms  Jiro Esaki, MD,

Clinical Outcomes of the David V Valve-Sparing Root Replacement Compared With Bioprosthetic Valve-Conduits for Aortic Root Aneurysms  Jiro Esaki, MD,
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N

Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N
Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.

Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.

Similar presentations

Ads by Google